Adar Poonawalla in the NRC Handelsblad - Bilthoven Biologicals

Terug naar het overzicht

At Bilthoven Biologicals we are very proud to be a part of the Cyrus Poonawalla Group and anxiously awaiting the results. We have a lot of faith! Thanks to the efforts of the Serum Institute and Mr. Adar Poonawalla hopefully soon there will be a COVID-19 vaccine to bring to low- and middle income countries and beyond by the Serum Institute of India.

Here you can read the interview (Dutch)

Meer Nieuws

Binnenkijken bij

Bij BBio zetten we kwaliteit voorop, de afdeling Quality Control maakt deze kwaliteit meetbaar

Bij BBio maken we betrouwbare vaccins in een kwalitatief hoogstaand productiebedrijf. Van elke productiebatch wordt bij BBio de veiligheid, werkzaamheid en identiteit gecontroleerd door de afdeling Quality Control (QC). Niet alleen producten worden getest, ook vele oppervlakten, het water en de lucht in de productieruimtes worden getest bij QC.

Bilthoven Biologicals leases GMP production facility to Batavia Biosciences

Bilthoven Biologicals (BBio), and Batavia Biosciences (Batavia), entered into a collaboration earlier this year whereby Batavia is manufacturing viral vaccines and viral vectors in a cGMP manufacturing facility (“Amalia facility”) from BBio.

Bilthoven Biologicals visited by Dutch Minister Kuipers and Indian Minister Khuba

Last week the Dutch Minister of Health, Ernst Kuipers and the Indian Minister of State for Chemicals and Fertilizers, New & Renewable Energy, Bhagwanth Khuba, made a visit to Bilthoven Biologicals (BBio) to view the progress made on the Pandemic Preparedness program.

Meer nieuws